Adam J. Townsend, Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 5,370 shares at $28.70 ($154K) on 2025-01-13, disclosed to the SEC on 2025-01-14.
Seasonal sale ($154k) by Chief Commercial Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.70 | 2,685 | $77K | 50.0% |
| 2 | $28.70 | 2,685 | $77K | 50.0% |
| Total | $28.70 avg | 5,370 | $154K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $132K | — | Filing → |
| APLS | SELL | 2024-02-13 | $156K | — | Filing → |
| APLS | SELL | 2024-01-31 | $116K | — | Filing → |